Načítá se...
Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major
Leishmania major (L. major) is a protozoan parasite causal agent of Leishmaniasis. It is estimated that 12 million people are currently infected and around 2 million infections occur each year. Current treatments suffer of high toxicity for the patient, low efficacy toward the parasite, high cost, a...
Uloženo v:
| Vydáno v: | Bioorg Med Chem Lett |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654408/ https://ncbi.nlm.nih.gov/pubmed/26410073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2015.09.041 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|